NSRX

Nasus Pharma
NSRX

Upgrade to unlock
Buy
Hold
Sell

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
Avg. target
$22
High target

1 analyst rating

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
L&C
Laidlaw & Co
Yale Jen
29 Sep ‘25 2 months ago